Original Research
Published on 25 Feb 2020
Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells
in Pharmacology of Anti-Cancer Drugs
- 4,406 views
- 15 citations
Original Research
Published on 25 Feb 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 21 Feb 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 13 Feb 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 13 Feb 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 11 Feb 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 04 Feb 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 28 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 23 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 21 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 17 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Hypothesis and Theory
Published on 17 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 15 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 14 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 09 Jan 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 20 Dec 2019
in Pharmacology of Anti-Cancer Drugs